Nuveen Asset Management

Nuveen Asset Management Portfolio holdings

AUM $354B
1-Year Return 34.48%
 

Nuveen Asset Management, founded in 1898 by John Nuveen and headquartered in Chicago, Illinois, is a leading global investment manager and subsidiary of TIAA, overseeing hundreds of billions in assets with a focus on fixed income, equities, and sustainable investing. Initially known for municipal bonds, Nuveen has expanded into a broad range of strategies, including mutual funds, ETFs, closed-end funds, and private capital solutions, serving institutional investors, financial advisors, and individuals. The firm emphasizes income-generating investments and ESG (environmental, social, governance) integration, leveraging its deep research capabilities and a century-long legacy in the bond market. With a strong presence in North America and growing international reach, Nuveen blends tradition with innovation to meet diverse client needs in the evolving investment landscape.

This Quarter Return
-3.74%
1 Year Return
+34.48%
3 Year Return
+60.43%
5 Year Return
+189.89%
10 Year Return
+390.34%
AUM
$309B
AUM Growth
-$29.4B
Cap. Flow
-$6.05B
Cap. Flow %
-1.96%
Top 10 Hldgs %
22.53%
Holding
3,386
New
44
Increased
1,590
Reduced
1,481
Closed
89

Sector Composition

1 Technology 24.82%
2 Financials 12.45%
3 Healthcare 12.44%
4 Consumer Discretionary 11.85%
5 Industrials 8.4%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
SEEL
3151
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
$210K ﹤0.01%
61
+1
+2% +$3.44K
SRT
3152
DELISTED
Startek Inc.
SRT
$210K ﹤0.01%
48,181
+1,032
+2% +$4.5K
JBIO
3153
Jade Biosciences, Inc. Common Stock
JBIO
$254M
$209K ﹤0.01%
409
CYD icon
3154
China Yuchai International
CYD
$1.29B
$209K ﹤0.01%
17,969
-1,068
-6% -$12.4K
SPOK icon
3155
Spok Holdings
SPOK
$359M
$209K ﹤0.01%
25,982
AMPE
3156
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$207K ﹤0.01%
1,606
GLSI icon
3157
Greenwich LifeSciences
GLSI
$149M
$206K ﹤0.01%
9,575
GTBP icon
3158
GT Biopharma
GTBP
$3.36M
$204K ﹤0.01%
2,362
+27
+1% +$2.33K
LEGH icon
3159
Legacy Housing
LEGH
$670M
$204K ﹤0.01%
8,329
SYRS
3160
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$202K ﹤0.01%
18,325
+266
+1% +$2.93K
THRX
3161
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
$202K ﹤0.01%
17,494
PPTA
3162
Perpetua Resources
PPTA
$1.98B
$201K ﹤0.01%
43,212
RLYB icon
3163
Rallybio
RLYB
$25.4M
$199K ﹤0.01%
+25,792
New +$199K
TYRA icon
3164
Tyra Biosciences
TYRA
$674M
$197K ﹤0.01%
18,400
IMRX icon
3165
Immuneering
IMRX
$229M
$196K ﹤0.01%
27,047
+15,287
+130% +$111K
SMED
3166
DELISTED
Sharps Compliance Corp
SMED
$194K ﹤0.01%
34,605
FORA icon
3167
Forian
FORA
$65.3M
$188K ﹤0.01%
29,305
DTP
3168
DELISTED
DTE Energy Company 2019 Corporate Units
DTP
0
-$184K
MBII
3169
DELISTED
Marrone Bio Innovations, Inc.
MBII
$188K ﹤0.01%
166,367
+5,573
+3% +$6.3K
PLSE icon
3170
Pulse Biosciences
PLSE
$1.02B
$186K ﹤0.01%
36,567
EBET
3171
DELISTED
EBET, INC. Common Stock
EBET
$185K ﹤0.01%
811
EPIX icon
3172
ESSA Pharma
EPIX
$11M
$181K ﹤0.01%
29,216
+2,397
+9% +$14.9K
RENT
3173
Rent the Runway
RENT
$24.8M
$179K ﹤0.01%
1,299
ACLX icon
3174
Arcellx
ACLX
$4.03B
$178K ﹤0.01%
+12,711
New +$178K
SMMT icon
3175
Summit Therapeutics
SMMT
$19.3B
$178K ﹤0.01%
54,748
-11,295
-17% -$36.7K